When destroying patient-specific medications from controlled floor stock, which of the following must be documented?

When destroying patient-specific medications from controlled floor stock, it is critical to maintain a comprehensive record to ensure proper accountability, traceability, and adherence to regulatory standards. Documenting the drug name, strength, dosage form, quantity, patient name, witness, destruction date, and method creates a complete audit trail, which is essential for compliance with state and federal regulations governing controlled substances.

The inclusion of the drug's name and strength along with its dosage form and quantity ensures that the specific medication being destroyed is accurately identified. Recording the patient's name ties the medication disposal back to the individual patient, which is vital in preventing errors and ensuring that records are accurate. A witness is necessary for verifying the destruction process, adding an additional layer of accountability. The destruction date is significant for tracking purposes, and documenting the method of destruction ensures that it adheres to established protocols which may be required by regulatory agencies.

In contrast, the other options do not provide a complete picture of the destruction process. They lack key elements such as the dosage form, quantity, and method, which are crucial for compliance and health care accountability. This thorough documentation helps protect the pharmacy legally and aids in maintaining patient safety.